Effects of Liquid Zinc Supplementation and Dispersible Zinc Tablets on Plasma Zinc Concentration

• Register: ClinicalTrials.gov
• Last refreshed on: 17 October 2012
• Main ID: NCT00944853
• Date of registration: 21/07/2009
• Primary sponsor: University of California, Davis
• Public title: Effects of Liquid Zinc Supplementation and Dispersible Zinc Tablets on Plasma Zinc Concentration
• Scientific title: The Effect of Zinc Supplementation, Provided as Either a Liquid Zinc Solution or Dispersible Tablets, on Plasma Zinc Concentration Among Young Burkinabe Children
• Date of first enrolment: August 2009
• Target sample size: 462
• Recruitment status: Completed
• URL: http://clinicaltrials.gov/show/NCT00944853
• Study type: Interventional
• Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention

Countries of recruitment

Burkina Faso

Contacts

• Name: Kenneth H Brown, MD
• Affiliation: University of California, Davis

Key inclusion & exclusion criteria

Inclusion Criteria:

- currently breast feeding

- informed consent of a parent or guardian.

Exclusion Criteria:

- symptomatic acute or chronic febrile infections

- diarrhea within the past week

- consuming vitamin or mineral supplements or zinc-fortified infant formulas



Age minimum: 6 Months
Age maximum: 23 Months
Gender: Both

Health Condition(s) or Problem(s) studied

Zinc Deficiency

Intervention(s)

Dietary Supplement: Liquid placebo supplement

Dietary Supplement: Liquid zinc supplement

Dietary Supplement: Zinc tablet

Primary Outcome(s)

Plasma zinc concentration [Time Frame: 3 weeks]

Secondary ID(s)

200917272

ZincTab

Source(s) of Monetary Support

Please refer to primary and secondary sponsors

Secondary Sponsor(s)

Helen Keller International

Institut de Recherche en Sciences de la Santé, Bobo-Dioulasso

Nutriset S.A.S.